(Q43600446)

25 November 2017

title

Inhibitors of advanced glycation end product-associated protein cross-linking (English)

1 reference

25 November 2017

T D Lehman

1

1 reference

25 November 2017

B J Ortwerth

series ordinal

2

1 reference

25 November 2017

publication date

1 February 2001

1 reference

Biochimica et Biophysica Acta

25 November 2017

published in

1 reference

25 November 2017

volume

1535

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

110-119

1 reference

Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Advanced glycosylation end products in diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Role of the Maillard reaction in diabetes mellitus and diseases of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Superoxide free radical generation by Amadori compounds: the role of acyclic forms and metal ions

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Nonenzymatic glycation of collagen in aging and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Characterization of a blue fluorophore isolated from in vitro reaction of N-proportional to-acetyllysine and 3-deoxyglucosone

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Free alanine, aspartic acid, or glutamic acid reduce the glycation of human lens proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Prevention of lens protein glycation by taurine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Inhibition of diabetes-associated complications by nucleophilic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Ibuprofen protects alpha-crystallin against posttranslational modification by preventing protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Determination of glycation crosslinking by the sugar-dependent incorporation of [14C]lysine into protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro. off.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Effect of germanium-132 on galactose cataracts and glycation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Preventive aspirin treatment of streptozotocin induced diabetes: blockage of oxidative status and revertion of heme enzymes inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Formation of advanced glycation end (AGE) products in diabetes: prevention by pyruvate and alpha-keto glutarate

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Protein glycation and in vivo distribution of human lens fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Nonenzymatic glucosylation of lysine residues in albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

A systematic approach to evaluate the modification of lens proteins by glycation-induced crosslinking

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Role of oxygen in cross-linking and chemical modification of collagen by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

Antioxidant properties of aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900087-9

7 January 2021

10.1016/S0925-4439(00)00087-9

Identifiers

DOI

1 reference

release_lfxaltmqpjc43c2jza77admnui

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lfxaltmqpjc43c2jza77admnui

24 November 2022

mapped directly with Wikidata item

1 reference